NCT07460765 2026-03-10Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)Vanderbilt-Ingram Cancer CenterPhase 1 Not yet recruiting40 enrolled